morpholine has been researched along with Drug Withdrawal Symptoms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Chen, X; Huang, M; Ji, M; Wang, Y | 1 |
| Cao, J; Dong, Z; Han, H; Luo, J; Tian, M; Xu, L; Xu, T; Zhong, W | 1 |
2 other study(ies) available for morpholine and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Design, synthesis and preliminary bioactivity evaluation of bitopic benzopyranomorpholine analogues as selective dopamine D3 receptor ligands as anti-drug addiction therapeutic agents.
Topics: Animals; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Design; Ligands; Mice; Molecular Structure; Morpholines; Naloxone; Receptors, Dopamine D3; Structure-Activity Relationship; Substance Withdrawal Syndrome | 2021 |
Stress evoked by opiate withdrawal facilitates hippocampal LTP in vivo.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Analysis of Variance; Animals; Dose-Response Relationship, Radiation; Drug Administration Schedule; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; Hormone Antagonists; In Vitro Techniques; Long-Term Potentiation; Male; Mifepristone; Morpholines; Patch-Clamp Techniques; Phenols; Piperidines; Rats; Rats, Sprague-Dawley; Stress, Psychological; Substance Withdrawal Syndrome; Time Factors | 2006 |